0001209191-22-016055.txt : 20220303
0001209191-22-016055.hdr.sgml : 20220303
20220303212107
ACCESSION NUMBER: 0001209191-22-016055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Nikita
CENTRAL INDEX KEY: 0001738061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 22711855
MAIL ADDRESS:
STREET 1: C/O AMNEAL PHARMACEUTICALS LLC
STREET 2: 400 CROSSING BLVD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001738061
Shah Nikita
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BLVD.
BRIDGEWATER
NJ
08807
0
1
0
0
Executive Vice President
Class A Common Stock
2022-03-01
4
M
0
11728
A
248649
D
Class A Common Stock
2022-03-01
4
F
0
3607
4.45
D
245042
D
Class A Common Stock
2022-03-01
4
M
0
28957
A
273999
D
Class A Common Stock
2022-03-01
4
F
0
8905
4.45
D
265094
D
Restricted Stock Units
2022-03-01
4
M
0
11728
0.00
D
Class A Common Stock
11728
11729
D
Restricted Stock Units
2022-03-01
4
M
0
28957
0.00
D
Class A Common Stock
28957
86873
D
Restricted Stock Units
2022-03-03
4
A
0
144928
0.00
A
Class A Common Stock
144928
144928
D
Performance-Based Restricted Stock Units
2022-03-03
4
A
0
289856
0.00
A
Class A Common Stock
289856
289856
D
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
The restricted stock units vest in four equal annual installments beginning on March 3, 2023.
Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Represents a performance-based restricted stock unit grant of 144,928 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period.
/s/ Meredith Cook, Attorney-in-Fact
2022-03-03